Zura Bio (ZURA) Short term Debt (2021)

Zura Bio's (ZURA) quarterly Short term Debt came in at $2872.0 in Q4 2021.

Zura Bio (ZURA) Short term Debt (2021) Analysis & Trends

Zura Bio's Short term Debt history runs 1 years deep, the most recent figure standing at $2872.0 for Q4 2021.

  • On a quarterly basis, Short term Debt changed N/A year-over-year to $2872.0 in Q4 2021; TTM through Dec 2021 was $2872.0, a N/A change from a year earlier, with the FY2021 full-year figure at $2872.0, changed N/A from the prior year.
  • Short term Debt held at $2872.0 in Q4 2021 per ZURA's latest filing.
  • Across five years, Short term Debt topped out at $2872.0 in Q4 2021 and bottomed at $2872.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Zura Bio 593.66 Mn 593.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 2,872.00